Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ylang ylang flower oil (Cananga odorata) contains linalool as its primary bioactive compound, comprising 7.28-28% of the essential oil composition. The oil demonstrates antioxidant activity with 63.8% DPPH inhibition and activates adrenergic receptors upon inhalation, contributing to its cardiovascular and mood-regulating effects.
Reported Benefits (Provisional)
Origin & History
Ylang Ylang Flower (Cananga odorata) is a highly aromatic bloom native to Southeast Asia and the Pacific Islands, thriving in tropical coastal and humid lowland forests. It is globally recognized for its exquisite fragrance and therapeutic essential oils, which offer significant benefits for emotional well-being and physiological balance.
Research Narrative (Provisional)
Studies, primarily focusing on its essential oil, demonstrate Ylang Ylang's anxiolytic and mood-uplifting effects through aromatherapy. Research also suggests its potential for cardiovascular benefits, including blood pressure regulation, and exhibits antimicrobial properties. While promising, most evidence is from in vitro or small human trials, warranting larger clinical studies.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals (Essential Oil Constituents): Linalool, Germacrene, Benzyl Acetate, Caryophyllene, Flavonoids, Phenolic Compounds, Esters, Alcohols, Terpenes
Reported Mechanism (Provisional)
Linalool and β-caryophyllene interact with adrenergic receptors upon inhalation, influencing cardiovascular parameters and stress response pathways. The oil's terpene compounds demonstrate potent antioxidant activity through DPPH radical scavenging (63.8% inhibition) and β-carotene bleaching inhibition (75.5%). Additional terpenoids like canangaterpene I inhibit melanogenesis more effectively than arbutin in melanoma cell assays.
Clinical Narrative (Provisional)
Current evidence derives primarily from in vitro and animal studies rather than human clinical trials. Laboratory studies show quantified antioxidant effects with 63.8 ± 0.45% DPPH inhibition and 80.06 ± 0.02% DPPH scavenging activity. Mouse studies demonstrate adrenergic receptor activation upon inhalation, but no randomized controlled trials have validated traditional uses for anxiety, depression, or hypertension. The antimicrobial and anti-melanogenesis effects require human validation through properly designed clinical studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.